Castle Biosciences (CSTL) Return on Sales (2018 - 2026)

Castle Biosciences (CSTL) has 9 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales slipped to 0.0% in Q1 2026 per CSTL's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q4 2024, with the low at 0.01% in Q1 2022.
• Average Return on Sales over 5 years is 0.0%, with a median of 0.0% recorded in 2022.
• Year-over-year, Return on Sales dropped 1 bps in 2022 and advanced 1 bps in 2024.
• Castle Biosciences' Return on Sales stood at 0.01% in 2022, then surged by 93 bps to 0.0% in 2023, then jumped by 385 bps to 0.0% in 2024, then tumbled by 124 bps to 0.0% in 2025, then slumped by 548 bps to 0.0% in 2026.
• Business Quant data shows CSTL's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.